| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.52 Billion | USD 3.54 Billion | 8.8% | 2024 |
FrequentlyAsked Questions
Thrombectomy devices are used to treat blood clots in the veins, arteries, and capillaries. These are meticulously developed devices to reduce blood loss while minimizing injury to the vascular wall during an operation. These devices are available in a variety of diameters and sizes, and the appropriate catheter is chosen based on the afflicted region. Disease and abnormalities such as peripheral arterial disorders, acute myocardial infarction, deep vein thrombosis, neurovascular thrombosis, and pulmonary embolism are all treated with these devices.
The global thrombectomy devices market is expected to grow due to rising prevalence of hypertension, increasing demand for continuous and ambulatory monitoring, advancements in wearable medical devices, and growing awareness of cardiovascular health management.
According to a study, the global thrombectomy devices market size was worth around USD 1.52 Billion in 2024 and is expected to reach USD 3.54 Billion by 2034.
The global thrombectomy devices market is expected to grow at a CAGR of 8.8% during the forecast period.
North America is expected to dominate the thrombectomy devices market over the forecast period.
Leading players in the global thrombectomy devices market include Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.), among others.
The report explores crucial aspects of the thrombectomy devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients